Tiza–Titre increase and enhanced immunity through an adjuvanted, recombinant herpes zoster subunit vaccine in patients with liver cirrhosis and post-liver transplantation: a study protocol for a prospective cohort study

Tiza–Titre increase and enhanced immunity through an adjuvanted, recombinant herpes zoster subunit vaccine in patients with liver cirrhosis and post-liver transplantation: a study protocol for a prospective cohort study

Introduction Shingrix, an effective adjuvanted, recombinant herpes zoster vaccine (RZV), has been available since 2018. Immunocompromised patients are known to be predisposed to vaccine failure. In-vitro testing of immunological surrogates of vaccine protection could be instrumental for monitoring v...

Full description

Bibliographic Details
Main Authors: Dorothea Dehnen, Tobias Boettler, Hartmut Hengel, Jürgen in der Schmitten, Suzan Botzenhardt, Benjamin Borchardt, Stephanie Vollmer-Raschdorf, Jassin Rashidi-Alavijeh, Sebastian Voigt, Daniela Huzly, Eva-Maria Hüßler, Anne Halenius, Katharina Willuweit, Mirko Trilling
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/11/e074461.full

Internet

https://bmjopen.bmj.com/content/13/11/e074461.full

Similar Items